Choice of reliable biochemical markers for assessment of bone remodeling in postmenopausal osteoporosis

Menopause

Volumn 4, Issue 4, 1997, Pages 212-218

  Shaarawy, Mohamed ^a,c   El Mallah, Samira Youssef ^b   Hassan, Hani Ez Eldin ^a   Aref, Ahmad Ibrahim ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

^c Roxy Building ^*  (Egypt)

Author keywords

Biochemical markers; Bone turnover; Postmenopausal osteoporosis

Indexed keywords

EID: 0007977688     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199704040-00007     Document Type: Article

References (5)

1. Parfitt AM. Quantum concept of bone remodelling and turnover: implications for the pathogenesis of osteoporosis. J Clin Invest 1987;72:1396-409.
2. Hilliker S, Libanati CR, Baylink DJ. The pathogenesis of primary osteoporosis. In: Slavkin H, Prie P, eds. Chemistry and biology of mineralized tissues. Amsterdam: Elsevier Science Publishers, 1992:455-63.
3. Delmas PD. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 1992;13:517-21.
4. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma PGP: an indicator of spontaneous bone loss and the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988;18:191-5.
5. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:1105-8.